| ALPHAMAB ONCOLOGY |
| China |
| Gesundheit |
| KYG0330A1013 / A2PWDV |
| 3NK (Frankfurt) |
| FRA:3NK, ETR:3NK, 3NK:GR |
| - |
| https://www.alphamabonc.c.. |
|
Alphamab Oncology is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative cancer therapies. Focusing on the Chinese and global markets, the company is committed to addressing unmet ..
>Volltext.. |
| 852.33 Mio. EUR |
| 704.15 Mio. EUR |
| 68.12 Mio. EUR |
| -10.85 Mio. EUR |
| -13.9 Mio. EUR |
| -0.01 EUR |
| 15.21 Mio. EUR |
| 32.02 Mio. EUR |
| - |
| 4.81 |
| -22.26% |
| -161.02% |
| - |
| - |
| - |
| - |
| ALPHAMAB |
| 02.04.26 |
|